TrialCancer medicine2024

Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China.

Siming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.